Health Care Articles on Seeking Alpha © seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (https://about.seekingalpha.com/terms). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited. SeekingAlpha.com https://seekingalpha.com Legend Biotech shares slide post-pricing of $226M public offering at $29.35 per unit https://seekingalpha.com/news/4604646-legend-biotech-shares-slide-post-pricing-of-226m-public-offering-at-2935-per-unit?source=feed_sector_health_care 4604646 Thu, 18 Jun 2026 01:57:14 -0400 LEGN Regentis Biomaterials to raise $6.5M via private placement https://seekingalpha.com/news/4604643-regentis-biomaterials-to-raise-65m-via-private-placement?source=feed_sector_health_care 4604643 Thu, 18 Jun 2026 01:31:50 -0400 RGNT Biogen to acquire RayThera in deal valued up to $1B https://seekingalpha.com/news/4604642-biogen-to-acquire-raythera-in-deal-valued-up-to-1b?source=feed_sector_health_care 4604642 Thu, 18 Jun 2026 01:25:47 -0400 BIIB Mineralys: Limited Differentiation Makes Lorundrostat A Weak Competitor https://seekingalpha.com/article/4915866-mineralys-limited-differentiation-makes-lorundrostat-a-weak-competitor?source=feed_sector_health_care 4915866 Wed, 17 Jun 2026 22:58:06 -0400 MLYS Stephen Ayers Hims & Hers Health: Legal Risks Resolved With New International Growth Driver - Maintain Buy https://seekingalpha.com/article/4915864-hims-legal-risks-resolved-with-new-international-growth-driver-maintain-buy?source=feed_sector_health_care 4915864 Wed, 17 Jun 2026 22:36:11 -0400 HIMS Juxtaposed Ideas Alkermes releases mid-stage alixorexton data for narcolepsy https://seekingalpha.com/news/4604610-alkermes-plummets-mid-stage-alixorexton-data-narcolepsy?source=feed_sector_health_care 4604610 Wed, 17 Jun 2026 17:07:01 -0400 ALKS CONMED names John Gallagher as chief financial officer https://seekingalpha.com/news/4604607-conmed-names-john-gallagher-as-chief-financial-officer?source=feed_sector_health_care 4604607 Wed, 17 Jun 2026 16:53:07 -0400 CNMD Certara names Faiz Mohammed interim CFO as John Gallagher steps down https://seekingalpha.com/news/4604606-certara-names-faiz-mohammed-interim-cfo-as-john-gallagher-steps-down?source=feed_sector_health_care 4604606 Wed, 17 Jun 2026 16:51:37 -0400 CERT Corcept resubmits relacorilant NDA for Cushing’s syndrome https://seekingalpha.com/news/4604602-corcept-resubmits-relacorilant-nda-cushings-syndrome?source=feed_sector_health_care 4604602 Wed, 17 Jun 2026 16:47:25 -0400 CORT uniQure: FDA's Latest Stance On Huntington's BLA Sends Stock Soaring https://seekingalpha.com/article/4915792-uniqure-fda-latest-stance-on-huntingtons-bla-sends-stock-soaring?source=feed_sector_health_care 4915792 Wed, 17 Jun 2026 15:40:38 -0400 QURE Edmund Ingham Pfizer: Why I'm Still Expecting A Massive Rebound https://seekingalpha.com/article/4915785-pfizer-why-im-still-expecting-a-massive-rebound?source=feed_sector_health_care 4915785 Wed, 17 Jun 2026 15:14:03 -0400 PFE PFE:CA ZPFE:CA Danil Sereda Verastem: 'Buy' Positive RAMP-205 Data And Extensive VS-7375 Registration Program https://seekingalpha.com/article/4915775-verastem-buy-positive-ramp-205-data-and-extensive-vs-7375-registration-program?source=feed_sector_health_care 4915775 Wed, 17 Jun 2026 14:43:08 -0400 VSTM Terry Chrisomalis Regenxbio, Replimune among gainers after FDA U-turn on UniQure https://seekingalpha.com/news/4604581-regenxbio-stock-gains-after-fdas-uniqure-u-turn?source=feed_sector_health_care 4604581 Wed, 17 Jun 2026 14:35:09 -0400 CAPR RGNX REPL QURE Intuitive Surgical: A Growth Story You Should Have On Your Radar https://seekingalpha.com/article/4915765-intuitive-surgical-a-growth-story-you-should-have-on-your-radar?source=feed_sector_health_care 4915765 Wed, 17 Jun 2026 13:46:18 -0400 XLV ISRG Vladimir Dimitrov, CFA Bayer Roundup settlement challenge returns to Missouri court https://seekingalpha.com/news/4604550-bayer-roundup-settlement-challenge-returns-to-missouri-court?source=feed_sector_health_care 4604550 Wed, 17 Jun 2026 13:32:07 -0400 BAYRY BAYZF uniQure soars as Cantor upgrades on plans to seek gene therapy nod https://seekingalpha.com/news/4604528-uniqure-stock-upgraded-cantor-fda-decision?source=feed_sector_health_care 4604528 Wed, 17 Jun 2026 13:14:04 -0400 QURE Eli Lilly: Pharma With Unstoppable Momentum Targets Pain With Latest M&A Deal https://seekingalpha.com/article/4915747-eli-lilly-pharma-with-unstoppable-momentum-targets-pain-with-latest-m-and-a-deal?source=feed_sector_health_care 4915747 Wed, 17 Jun 2026 12:58:10 -0400 NVO NOVO:CA NONOF NVON:CA PFE PFE:CA ZPFE:CA LLY LLY:CA ZLLY:CA Edmund Ingham J&J avoiding GLP-1 space to focus on cancer drugs https://seekingalpha.com/news/4604478-j-and-j-avoiding-glp-1-space-focus-cancer-drugs?source=feed_sector_health_care 4604478 Wed, 17 Jun 2026 12:20:51 -0400 JNJ AMGN PFE NVO LLY AZN CG Iovance Biotherapeutics: Commercial, Clinical, And Regulatory Tailwinds https://seekingalpha.com/article/4915694-iovance-biotherapeutics-commercial-clinical-and-regulatory-tailwinds?source=feed_sector_health_care 4915694 Wed, 17 Jun 2026 11:31:00 -0400 IOVA Biotech Beast GSK, Spero win approval of Utebzi for complicated urinary tract infections https://seekingalpha.com/news/4604454-gsk-spero-win-approval-utebzi-complicated-urinary-tract-infections?source=feed_sector_health_care 4604454 Wed, 17 Jun 2026 11:30:32 -0400 GSK SPRO